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Abstract
Background: In the analysis of effects by cell treatment such as drug dosing, identifying changes on gene
network structures between normal and treated cells is a key task. A possible way for identifying the changes is to
compare structures of networks estimated from data on normal and treated cells separately. However, this
approach usually fails to estimate accurate gene networks due to the limited length of time series data and
measurement noise. Thus, approaches that identify changes on regulations by using time series data on both
conditions in an efficient manner are demanded.
Methods: We propose a new statistical approach that is based on the state space representation of the vector
autoregressive model and estimates gene networks on two different conditions in order to identify changes on
regulations between the conditions. In the mathematical model of our approach, hidden binary variables are newly
introduced to indicate the presence of regulations on each condition. The use of the hidden binary variables
enables an efficient data usage; data on both conditions are used for commonly existing regulations, while for
condition specific regulations corresponding data are only applied. Also, the similarity of networks on two
conditions is automatically considered from the design of the potential function for the hidden binary variables.
For the estimation of the hidden binary variables, we derive a new variational annealing method that searches the
configuration of the binary variables maximizing the marginal likelihood.
Results: For the performance evaluation, we use time series data from two topologically similar synthetic networks,
and confirm that our proposed approach estimates commonly existing regulations as well as changes on
regulations with higher coverage and precision than other existing approaches in almost all the experimental
settings. For a real data application, our proposed approach is applied to time series data from normal Human
lung cells and Human lung cells treated by stimulating EGF-receptors and dosing an anticancer drug termed
Gefitinib. In the treated lung cells, a cancer cell condition is simulated by the stimulation of EGF-receptors, but the
effect would be counteracted due to the selective inhibition of EGF-receptors by Gefitinib. However, gene
expression profiles are actually different between the conditions, and the genes related to the identified changes
are considered as possible off-targets of Gefitinib.
Conclusions: From the synthetically generated time series data, our proposed approach can identify changes on
regulations more accurately than existing methods. By applying the proposed approach to the time series data on
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normal and treated Human lung cells, candidates of off-target genes of Gefitinib are found. According to the
published clinical information, one of the genes can be related to a factor of interstitial pneumonia, which is
known as a side effect of Gefitinib.
Background
Gene network estimation from time series gene expres-
sion data is a key task for elucidating cellular systems.
Thus far, wide variety of approaches have been proposed
based on the vector autoregressive (VAR) model [1,3],
the state space model [4-6], and the dynamic Bayesian
network [7,8]. Recently, time series gene expression data
on multiple conditions aiming at analyzing effects of cell
treatment such as drug dosing and heat shock are avail-
able. We here assume that some gene regulations are
disrupted but many of the gene regulations do not
change due to some treatment of interest, and try to
find a small number of changes on regulations as keys
for elucidating effects by the treatment.
A possible way for finding changes on regulations is to
estimate networks from two data sets separately and
then compare their structures. However, due to the lim-
ited length of time series data (usually less than 10 time
points) and unignorable measurement noise, networks
are estimated with high error rates and the estimation
errors cause the serious failure on identifying changes
on regulations. Thus, approaches using two time series
data in an efficient manner are strongly demanded.
Also, widely used statistical methods such as the VAR
model and dynamic Bayesian network assume equally
spaced time points in time series data. However,
observed time points on usually available time series
data are not equally spaced [5,6,9], and approaches that
can handle unequally spaced time series data in a theo-
retically correct way should be considered.
We propose a new statistical model that estimates
gene networks on two different conditions in order to
identify changes on regulations between the conditions.
As the basis of the proposed model, we employ the
state space representation for VAR model (VAR-SSM),
in which observation noise is considered between the
measured or observed gene expressions and the true
gene expressions in observation model and gene regula-
tions between true gene expressions are considered in
the system model [10]. The VAR-SSM can handle
unequally spaced time series data by ignoring observa-
tion model on the non-observed time points. For con-
sidering the changes on regulations, we introduce
hidden variables to the VAR-SSM in order to indicate
the presence of regulations in each condition. If hidden
binary variables on two conditions indicating the pre-
sence of a regulation are both estimated as one, the reg-
ulation is considered as a commonly existing regulation.
On the other hand, if only one of the hidden binary
variables for the regulation is estimated as one, the reg-
ulation is considered as a condition specific regulation.
We also introduce a potential function between the hid-
den binary variables that is designed to take high prob-
ability if the hidden binary variables on two conditions
take the same value. From the design of the potential
function, the similarity of networks on two conditions is
automatically considered. Since the time series data on
both conditions are used for estimating commonly
existing regulation due to the use of the hidden binary
variables, an efficient data assignment is achieved. In
addition, from the more accurate estimation of com-
monly existing regulations by the efficient data assign-
ment, accurate identification of changes on regulations
is induced.
The hidden binary variables are estimated by search-
ing the configuration of binary variables that maximizes
the marginal likelihood of the model. However, search-
ing the optimal configuration is computationally intract-
able. Thus, as an alternative approach, we derive a new
variational annealing method based on [11] in order to
estimate the hidden binary variables. We also give a
proof for the effectiveness of the variational annealing
compared to other candidate alternatives, the variational
annealing and the EM algorithm, in order to show the
validity of using the variational annealing.
Table 1 Comparison of the variation annealing
(Proposed) and EM algorithm (EM) based on the
proposed model
(a)
# of time points 50 25
# TP # FP PRE # TP # FP PRE
Proposed 295.9 41.7 0.88 238.4 71.6 0.77
EM 294.9 119.2 0.71 196.8 66.9 0.75
(b)
# of time points 50 25
# TP # FP PRE # TP # FP PRE
Proposed 39.8 13.2 0.75 23.4 20.8 0.53
EM 39.9 39.4 0.5 11.5 10.0 0.53
(a) The number of true positives (# TP) and false positives (# FP) of estimated
regulations in two network models by the proposed approach and EM for
equally spaced time series data. PRE denotes the precision of the results.
Regulations in two networks are 305 in total. (b) The number of true positives (#
TP) and false positives (# FP) of changes on regulations between two network
models estimated by the proposed approach and EM for equally spaced time
series data. The regulations changed in two networks are in total 47.
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For the performance evaluation, we generate two reg-
ulatory networks in such a way that most of the regula-
tions commonly exist and some exist only on one of the
networks. We then apply our proposed approach and
existing var model based and dynamic Bayesian network
based approaches to two equally spaced time series data
drawn separately from the generated networks. From
the comparisons of true positive rates and false positive
rates of these approaches, we confirm the effectiveness
of our approach. We also generate unequally spaced
time series data from these networks, and show that our
approach works correctly on unequally spaced time ser-
ies data while the performance of the existing
approaches assuming equally spaced time points is dras-
tically worsened.
Our proposed approach is used to analyze changes on
regulations in gene networks between normal Human
lung cells and Human lung cells treated by stimulating
EGF-receptors and dosing an anticancer drug termed
Gefitinib. A lung cancer condition is simulated by the
stimulation of EGF-receptors in the treated cells. Since
Gefitinib is known as a selective inhibitor of EGF-recep-
tors, the stimulation of EGF-receptors would be coun-
teracted by Gefitinib, and hence the treated cells are
expected to be the same condition as normal cells.
However, gene expression profiles from normal and
treated cells are actually different, and off-targets of
Gefitinib causing unexpected positive or negative effects
are implied. We focus on genes with changes on regula-
tions between the networks estimated by our approach
and find possible off-target genes of Gefitinib. According
to the published clinical information, one of the possible
off-target genes is suggested as one of factors of intersti-
tial pneumonia, which is known as a side effect of
Gefitinib.
Methods
Vector autoregressive model and its state space
representation
Vector autoregressive model
Given gene expression profile vectors of p genes during
T time points {y1, ..., yT}, the first order vector autore-
gressive (VAR(1)) model at time point t is given by
yt = Ayt−1 + ε1,
where A is a p × p autoregressive coefficient matrix,
and εt is observation noise at time t and follows
N (0, diag[σ 21 , ..., σ 2p ]), a normal distribution with mean
0 and variance diag[σ 21 , ..., σ
2
p ]. The (i, j)th element of A,
Aij, indicates a temporal regulation from the jth gene to
the ith gene, and if Aij ≠ 0, regulation from the jth gene
to the ith gene is considered. By examining whether Aij
is zero or not for all i and j, a gene network is
constructed. Since equally space time points are
assumed in the VAR model, it has difficulty on handling
unequally spaced time series data.
State space representation of VAR model (VAR-SSM)
Let T be the set of equally spaced entire T time points
and Tobs the set of time points where gene expressions
are observed. Note that Tobs ⊆ T holds. VAR-SSM is
comprised of two models: system model and observation
model. Let xt be hidden variable vector representing
true gene expression at time t. The system model is
given as the VAR model of xt:
xt = Axt−1 + ηt, t ∈ T ,
where ht is the system noise normally distributed with
mean 0 and variance H = diag[h1,...,hp]. The observation
model represents measurement error of observed gene
expression yt and true gene expression xt at observed
time point t ∈ Tobs:
yt = xt + ρt, t ∈ Tobs,
where rt is the observation noise normally distributed
with mean 0 and variance R = diag[r1,..., rp]. Unequally
spaced time series data are handled by ignoring observa-
tion model at non-observed time points.
Joint model of VAR-SSM for two time series data
Let {y(c)t }t∈T (c)obs be time series gene expression data on cell
condition c, where T (c)obs is the set of observed time
points on cell condition c. We also let T (c) be the set of
time points from 1 to T(c), where T(c) = max{t ∈ T (c)obs }.
Given time series data on two types of cell conditions c
= 1 and 2, we propose a new VAR-SSM model to esti-
mate gene networks in the two conditions as well as
identify changes on regulations between them. The
model is comprised of the following two equations:
x(c)t = A ◦ E(c)x(c)t−1 + η(c)t , t ∈ T (c),
y(c)t = x
(c)
t + ρ
(c)
t , t ∈ T (c)obs ,
where ∘ denotes the Hadamard product, E(c) is a p × p
binary matrix, and η(c)t and ρ
(c)
t are respectively system
and observation noises from N (0,H) and N (0,R). In
this model, the (i, j)th element E(c)ij takes one if regula-
tion from gene j to gene i exists on condition c and
zero otherwise, i.e., the presence of regulations is con-
trolled by E(c) and the AR coefficient matrix A is com-
monly used in conditions 1 and 2. Changes on
regulations are identified when regulations exist only in
a condition.
The complete likelihood of our model, P(Y, X, Θ, E),
where Y, X, Θ, and E are respectively the sets of y(c)t , x
(c)
t ,
parameters, and E(c), is given by the following equation:
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P(Y,X,,E) =
2∏
c=1
∏
t∈T (c)
|H|−1/2√
2π
p exp
{
−1
2
(x(c)t − A ◦ E(c)x(c)t−1)′H−1(x(c)t − A ◦ E(c)x(c)t−1)
}
×
∏
t∈T (c)obs
|R|−1/2√
2π
p exp
{
−1
2
(y(c)t − x(c)t )′R−1(y(c)t − x(c)t )
}
P(,E),
where the prior distribution P(Θ, E) is assumed to be
factorized as
P(,E) =
∏
i
P(hi)P(ri)
∏
j
P(Aij)P(E
(1)
ij ,E
(2)
ij , zij).
Here, zij is a parameter for a potential function of E
(1)
ij
and E(2)ij defined later. The prior distributions of Aij is
given by
P(Aij|hi,E(1)ij ,E(2)ij ) = N (Aij; 0, hi · α1)FijN (Aij; 0, hi · α0)1−Fij ,
where a0 and a1 are parameters controlling the
shrinkage of coefficients A and Fij is a binary variable
that takes 1 if E(1)ij or E
(2)
ij takes 1 and 0 otherwise, i.e.,
Fij is given by 1 −
∏2
c=1 (1 − Ecij). a1 is set to a large
value, while a0 is set to smaller than a1. From the
design of the prior for Aij, if E
(1)
ij or E
(2)
ij takes one, i.e.,
there exists regulation from gene j to i in condition 1 or
2, weaker prior N (Aij; 0, hi · α1) is selected and the
shrinkage of the coefficients are avoided. Otherwise
stronger prior N (Aij; 0, hi · α0) is selected and the spar-
sity of the network structures is promoted. The prior
distributions of hi , and ri are given by
P(hi) = IG(hi; u0, k0),
P(ri) = IG(ri; v0, l0),
where IG represents the density function of inverse
gamma distribution, u0 and v0 are the shape parameters,
and k0 and l0 are the inverse scaling parameters. Under
the assumption that a small number of regulations
change between two conditions, we design the prior dis-
tribution for E(1)ij and E
(2)
ij ,P(E
(1)
ij ,E
(2)
ij , zij) by using the fol-
lowing potential function between E(c)ij for c = 1 or 2:
1
2
φ(E(1)ij ,E
(2)
ij ; zij) =
{
zij if E
(1)
ij = E(2)ij
1 − zij otherwise
.
In this setting, if zij is small, E
(1)
ij and E
(2)
ij tend to take
the same value and thus most of the regulations exist in
both two conditions. We also introduce a prior distribu-
tion for zij by beta distribution with parameters ζi0 and
ζi1:
B(zij; ζi0, ζi1) = 1
B(ζi0, ζi1)
zζi0−1ij (1 − zij)ζi1−1,
where B(·) is the beta function. Thus, the prior distri-
bution of E(c)ij is given by
P(E(1)ij ,E
(2)
ij , zij) = φ(E
(1)
ij ,E
(2)
ij )B(zij; ζi0, ζi1).
Figure 1 shows a graphical representation of the pro-
posed model, where dependency of the parameters and
variables are indicated. The hyperparameters are
omitted and the observed data yt is represented by gray
nodes. In the observed data y(1)t and y
(2)
t are propagated
mainly via hidden variables E(1)ij and E
(2)
ij . Due to the
data propagation, more accurate estimation is expected
in the proposed model than the approaches considering
data on two conditions independently.
For the parameter estimation, we search the config-
uration of E maximizing the following marginal likeli-
hood:
Eˆ = argmax
E
∫
dX
∫
dP(Y,X,,E). (1)
Finding the optimal configuration of E is computa-
tionally intractable, and heuristics approaches such as
the EM algorithm and the variational method are used
in practice. Here, we use the variational annealing, an
extension of the deterministic annealing for discrete
variables [11]. In the next section, we give a small expla-
nation of the variational annealing and show its effec-
tiveness compared to the EM algorithm and the
variational method.
Parameter estimation by variational annealing
In the deterministic annealing, optimization problem is
solved while gradually changing temperature in a some
schedule, and maximum likelihood estimator is obtained
like the EM algorithm [12-14]. Yoshida and West pro-
posed to use the deterministic annealing to find the
configuration of the binary variables that maximizes the
likelihood of factor models with sparseness priors [11].
We derive a new variational annealing method by
extending Yoshida and West’s approach to find the con-
figuration of the binary variables on marginal likelihood
function, which can be applied for searching E that
maximizes Equation (1).
Let E, X, and Θ be p dimensional binary variables,
unobserved variables, and parameters, respectively, and
consider to search E maximizing the following marginal
likelihood:
max
E∈{0,1}p
log
∫
dX
∫
dP(X,,E). (2)
The maximum of the marginal likelihood on E is
bounded by the following formula:
max
E∈{0,1}p
log
∫
dX
∫
dP(X,,E) ≥ τ log
∫
(0,1)p
dE
[∫
dX
∫
dP(X,,E)
]1/τ
, (3)
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where τ is called temperature and the equality holds
for τ ® +0. Hereafter, the integral range of E is
omitted if no confusion occurs. Let Q(E) be a normal-
ized non-negative function, i.e., Q(E) ≥ 0 and ∫ Q(E)dE
= 1.
From the Gibbs inequality, the right side of Equation
(3) is also bounded:
τ log
∫
dE
[∫
dX
∫
dP(X,,E)
]1/τ
≥
∫
dEQ(E) log
∫
dX
∫
dP(x,,E)
Q(E)τ
.
Here, Q(E) is considered as an approximation function
of
P(E)1/τ∫
P(E′)1/τdE′
. Under the assumption that P(X,Θ,E) ∝ Q
(X)Q(Θ), where Q(X) and Q(Θ) are normalized non-
negative functions, we have the following inequality
Figure 1 A graphical representation of the proposed model. Hyperparameters are omitted from this representation. The nodes in gray
denote observed data.
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∫
dEQ(E) log
∫
dX
∫
dP(X,,E)
Q(E)τ
≥
∫
dE
∫
dX
∫
dQ(X)Q()Q(E) log
P(X,,E)
Q(X)Q()Q(E)τ
. (4)
Thus, as an approximation of E maximizing Equation
(2), we try to find Eˆ = argmaxEQ(E), where Q(E) is the
function maximizing the lower bound in Equation (4).
Since higher values on P(E) are weighed more in the
approximation by Q(E) for τ < 1, the better approxima-
tion is expected for the higher values. This property on
the limited case is shown in Proposition 1. As is in the
variational method and the EM algorithm, the maxi-
mum of the lower bound in Equation (4) is searched by
a hill climbing from high temperature τ > 1.
In the hill climbing, Q(X), Q(Θ), and Q(E) are alter-
nately updated from the following equations:
Q(E) ∝ exp
(
1
τ
∫
dX
∫
dQ(X)Q() log P(E|X,)
)
,
Q(X) ∝ exp
(∫
dE
∫
dQ(E)Q() log P(X|,E)
)
,
Q() ∝ exp
(∫
dE
∫
dXQ(E)Q(X) log P(|X,E)
)
.
Gradually converging τ to 0, local optimum of the
lower bound and corresponding Q(E), Q(X), and Q(Θ)
are obtained.
Effectiveness of variational annealing
As alternatives of the variational annealing, we may con-
sider the variational method and the EM algorithm
where X is the set of hidden variables and E is handled as
the set of parameters to be maximized. We show the
effectiveness of variational annealing compared to the
variational method and the EM algorithm under the fol-
lowing conditions: P(X, Θ, E) is factorized into P(X, E)P
(Θ, E), and P(Ei|X, Θ, E\{Ei}) is given as a binomial distri-
bution, where Ei is the ith element of E. If factorization
of P(X, Θ, E) = Q(X)Q(Θ)Q(E) is assumed in the calcula-
tion of the variational method, arg maxE Q(E) is not the
optimal solution of Equation (2) in general. In the EM
algorithm, by allowing E to move around a p-dimensional
continuous space (0, 1)p, EˆEM = argmaxE∈(0,1)mP(E) can
be calculated. Let EˆEM,i be the ith element of EˆEM.
Usually, EˆEM,i is mapped to 1 if EˆEM, i > 0.5 and 0 other-
wise for discretizing EˆEM to the p-dimensional binary
space {0,1}p, but such a mapping is not guaranteed to
provide argmaxE∈{0,1}mP(E). Although other mappings
can be considered, to the best of our knowledge, no map-
ping is guaranteed to provide the optimal solution in
polynomial time of p.
In the following, we prove a proposition in order to
show that the variational annealing possibly give the
optimal solution of Equation (2) even if the factorization
of Q(E) =
∏p
i=1 Q(Ei) is additionally considered.
Proposition 1. P(X,Θ,E) is factorized into P(Θ,E)P(X,
E), and P(Ei|X,Θ,E\{Ei}) is given as a binomial distribu-
tion. Let Qˆ(Ei)be Q(Ei) maximizing the lower bound of
the variational annealing for τ ® +0 given by
∫
dE1...
∫
dEp
∫
dX
∫
dQ(X)Q()
∏
i
Q(Ei) log
P(X,,E)
Q(X)Q()
∏
i Q(Ei)
τ . (5)
Then, the set of Ei Î {0,1} maximizing EˆEMis
argmaxE∈{0,1}pP(E).
For the proof of the proposition, see Section 1 in
Additional file 1. From Proposition 1, if the factorization
P(X, Θ, E) = P(Θ, E)P(X, E) is satisfied and optimal Q
functions are found, the variational annealing is guaran-
teed to provide the optimal solution of Equation (2)
while the variational method and the EM algorithm are
not. Although the factorization is not a generally satis-
fied property, the factorization is often assumed in
approaches based on the variational method, and the
assumption usually works as good approximations.
Thus, the variational annealing is expected to provide
the better performance than the variational method and
the EM algorithm even if the factorization is not satis-
fied exactly.
Procedures of variational annealing on proposed model
In the variational annealing on the proposed model, we
calculate Q functions for hidden variables X, parameters
Θ, and binary variables E iteratively while cooling tem-
perature τ to zero gradually at each iteration cycle. In
the following, we show the calculation procedures of Q
(X), Q(Θ), and Q(E) on the proposed model as varia-
tional E-step, variational M-step, and variational A-step,
respectively. More details of the procedures are given in
Additional file 1. For the notational brevity, we denote
the expectation of a value x with a probability distribu-
tion Q(y) as 〈x〉Q(y).
Variational E-step
Parameters of Q(X) are mean of xt, variance of xt, and
cross time variance of xt-1 and xt. These parameters can
be calculated via variational Kalman filter by using fol-
lowing terms expected with Q(Θ)Q(E): 〈E(c)〉Q(Θ)Q(E), 〈A〉Q
(Θ)Q(E), 〈H
-1 A ○ E(c)〉Q(Θ)Q(E), and 〈(A ○ E(c))’H-1A ○ E(c)〉Q
(Θ)Q(E). For the details of variational Kalman filter, see [4].
From the parameters of Q(X), expectations of the follow-
ing terms with Q(X) required in other steps are calcu-
lated:
〈
x(c)t
〉
Q(X)
, 〈x(c)t
(
x(c)t
)′
〉Q(X), and 〈x(c)t+1
(
x(c)t
)′
〉Q(X).
Variational M-step
Q(Θ) is factorized into ∏iQ(Ai|hi) Q(hi)Q(ri) ∏jQ(zij),
where Ai is a vector given by (Ai1, ..., Aip)’. From the
design of the proposed model, Q(Ai|hi), Q(hi), Q(ri), and
Q(zij) are given in the following form:
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Q(Ai|hi) = N (Ai;μAi , hiT−1Ai ),
Q(hi) = IG(hi; ui, ki),
Q(ri) = IG(ri; vi, li),
Q(zij) = B(ζij,0; ζij,1).
Parameters for the above functions are calculated by
using 〈x(c)t 〉Q(X), 〈x(c)t
(
x(c)t
)′
〉Q(X), 〈x(c)t+1
(
x(c)t
)′
〉Q(X),, and
〈E(c)ij 〉Q(E).
Variational A-step
For the calculation of Q(E), we assume the factorization
of Q(E) to
∏
c
∏
ij Q(E
(c)
ij ) in order to make the computa-
tion tractable. Q(E(c)ij ) follows a binomial distribution
that takes one with probability e(c)ij and zero with prob-
ability 1 − e(c)ij , and thus the expectation of E(c)ij with Q
(E) is given by e(c)ij . For the preparation, we calculate
〈A〉Q(), 〈H−1A〉Q(), 〈A′H−1A〉Q(), 〈x(c)t 〉Q(X), 〈x(c)t
(
x(c)t
)′
〉Q(X),
and 〈x(c)t+1
(
x(c)t
)′
〉Q(X). Q(E(c)ij ) is then iteratively calculated
by using these expected terms as well as 〈E(c)ik 〉Q(E) for k
≠ j. A few iterations are enough for the convergence.
Update and selection of hyperparameters
The proposed model contains u0, k0, v0, l0, ζi0, ζi 1, a0,
and a1 as hyperparameters. a0 and a1 should be a0 <a1
as in the model setting, but this condition can be vio-
lated in the update step of the variational method. Thus,
we select a0 and a1 by cross validation, and update
other hyperparameters as in the variational method.
We first consider update of hyperparameters u0, k0, v0,
l0, ζi0, and ζi1 to increase the lower bound of marginal
probability. u0 and k0 are updated by maximizing the
following equation:
(uˆ0, kˆ0) = arg max
(u0,k0)
∑
i
∫
Q(hi) log IG(hi; u0, k0)dhi
= arg max
(u0,k0)
(u0 − 1)
∑
i 〈log hi〉Q(hi)
p
+ u0 log k0 − k0
∑
i 〈1/hi〉Q(hi)
p
− log	(u0).
uˆ0 and kˆ0 are obtained by numerical optimization
methods such as the Newton-Raphson method. v0 and
l0 are also updated in a similar manner to u0 and k0. ζi0
and ζi1 are updated by solving the following equation:
(ζˆi0, ζˆi1) = argmax
ζi0,ζi1
∑
j
∫
Q(zij) logB(zij; ζi0, ζi1)dzij
= argmax
ζi0,ζi1
(ζi1 − 1)
∑
j 〈log(1 − zij)〉Q(zij)
p
+ (ζi0 − 1)
∑
j 〈log zij〉Q(zij)
p
− logB(ζi0, ζi1).
ζˆi0 and ζˆi1 can also be obtained by the Newton-Raph-
son method.
For the selection of a0 and a1, we set a1 to some
large value and select a0 by a leave one out cross valida-
tion procedure. For condition c Î {1, 2} and time point
t ∈ T (c)obs , we remove y(c)t from data set y and use the data
set to train the model. We calculate square sum of resi-
dues r2t,c between y
(c)
t and the prediction of x
(c)
t estimated
from the variational Kalman filter on the trained model
given by r2t,c = (y
(c)
t − x(c)t )′(y(c)t − x(c)t ). By grid search on
parameter space of a0, we select a0 that minimizes∑2
c=1
∑
t∈T (c)obs
r2t,c.
Summary of procedures
The procedures for estimating parameters in the pro-
posed model are summarized as follows:
1. Set τ to some large value. Also set a0 to a small
value and a1 to a large value satisfying that a0 <a1.
2. Initialize other hyperparameters and hidden
variables.
3. Perform the following procedures:
(a) Calculate variational M-step.
(b) Update hyperparameters.
(c) Calculate variational E-step.
(d) Calculate variational A-step.
(e) Go back to step (a) until some convergence
criterion is satisfied.
4. Divide τ by some value > 1 such as 1.05.
5. Go back to step 3 if τ is larger than some very
small value > 0.
In our setting, a1 is set to 1,000. For the initialization
of τ and other hyperparameters, we use the following
settings: τ = 2.5,E(c)ij = 0.5, ui = 1, ki = 1, vi = 1, li = 1, ζi0 = 10, and ζi1 = 10.
If y(c)t is observed, we initialize x
(c)
t with y
(c)
t . Otherwise,
we use the linearly interpolated one.
Results and discussion
Performance evaluation by Monte Carlo experiments
For the evaluation of the proposed approach, we gener-
ate two linear regulatory network models with similar
topological structures G1 and G2 based on a linear regu-
latory network model G0. G0 is prepared in the follow-
ing manner: (i) a scale free network of 100 nodes and
150 edges is generated; (ii) edge directions are assigned
randomly; (iii) autoloop edges are added to root nodes
of the directed network; and (iv) AR coefficients for the
directed edges are chosen randomly from {-0.9, -0.8,
-0.7, -0.6, -0.5, 0.5, 0.6, 0.7, 0.8, 0.9}. We then generate
G1 and G2 from G0 as follows: (i) autoloop edges and
70% of non-autoloop edges in G0 are used for com-
monly existing edges in G1 and G2; and (ii) the other
30% of non-autoloop edges are randomly assigned as
either G1 or G2 specific edges. Note that AR coefficients
on edges of G1 and G2 are preserved, i.e., if a regulation
from gene j to gene i exists in G1 or G2, then its coeffi-
cient is the same as that of the regulation from gene j
to gene i in G0.
Figure 2 gives graph structure of G1 and G2, where
commonly regulations, G1 specific regulations, and G2
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specific regulations are represented with black, red, and
green arrows, respectively.
From each of G1 and G2, we obtain two equally
spaced time series data of 25 time points and 50 time
points. For system noise and observation noise, normally
distributed values with mean 0 and standard deviation 1
and mean 0 and standard deviation 0.1 and 1 are used,
respectively. The signal-noise ratio for system noise with
standard deviation 1 and observation noise with stan-
dard deviation 0.1 is 0.03dB, and the signal is bit stron-
ger than the noise. On the other hand, for observation
noise with standard deviation 1, the signal-noise ratio is
-0.26dB. In the condition, the noise is stronger than the
signal, and the noise level is quite high.
Comparison between variational annealing and EM
algorithm
We first compare the performances of the proposed
approach and the approach that is based on the pro-
posed approach but uses the EM algorithm instead of
the variation annealing using the equally spaced time
series data of 50 and 25 time points on the system noise
with standard deviation 1 and observation noise with
standard deviation 0.1. From the comparison, we verify
the effectiveness of the variational annealing, compared
to the EM algorithm. Table 1 summarizes the results of
the proposed approach and the EM algorithm based
approach. For the EM algorithm, the regulation from j
to i on condition c is considered to exist if the estimated
E(c)ij is more than 0.5.
From the comparison, the results of the proposed
approach contain more true positives than those of the
EM algorithm based approach except for identifying
changes on regulations for time points 50. For identify-
ing changes on regulations, the EM algorithm based
approach estimates bit more true positives than the pro-
posed approach, but the difference is so small that it
can be ignored. On the other hand, the results of the
EM algorithm based approach contain more false posi-
tives than those of the proposed approach, and hence
the precision of the results by the EM algorithm is
Figure 2 The graph structures of G1 and G2. Commonly regulations, G1 specific regulations, and G2 specific regulations are represented with
black, red, and green arrows, respectively.
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worse than that of the proposed approach. Therefore,
the effectiveness of the variational annealing is con-
firmed in the computational experiment as well.
Comparison between proposed approach and existing
approaches
We employ the elastic net based VAR model approach
[2] and the dynamic Bayesian network based approach
termed G1DBN [8] as existing approaches for estimating
networks from time series data. For the experiments,
two versions of these approaches are considered: ENet1
and ENet2 from the elastic net based VAR model
approach, and G1DBN1 and G1DBN2 from G1DBN.
These approaches are different in the following point:
ENet1 and G1DBN1 estimate G1 and G2 independently,
i.e., for the estimation of G1, only time series data from
G1 is used, while ENet2 and G1DBN2 assume that G1
and G2 have the same network structure and estimate a
network by using two time series data. Thus, ENet2 and
G1DBN2 are considered to more use data sample than
ENet1 and G1DBN1 for network estimation, but
changes on regulations between G1 and G2 are not con-
sidered. For selection of hyperparameters in ENet1 and
ENet2, AICc is used [2], and for hyperparameters a1
and a2 of G1DBN1 and G1DBN2, a setting of a1 = 0.1
and a2 = 0.0059 considered in [8] is used.
For the comparison of these approaches, we focus on
the following two points: the number of correctly
estimated regulations and the number of correctly esti-
mated changes on regulations. The former is usually
considered for evaluating the performance of gene net-
work estimation methods. The numbers of true positives
and false negatives of the estimated regulations are sum-
marized in Table 2(a). The precisions of the results
given by
The number of true positives
The number of true positives + The number of false positives
are also provided. The results are averaged on ten data
sets. The number of regulations in the true network
models of G1 and G2 are in total 305. For the latter
point, we consider the estimated regulations existing
only in one of two estimated networks as changed regu-
lations, and check if they correctly exist only in the cor-
responding true network. The numbers of true positives
and false negatives of the estimated changes on regula-
tions and the precisions are summarized in Table 2(b).
The results are also averaged on ten data sets. The
number of true changes on regulations between in G1
and G2 are 47, i.e., the number of true positives on this
case is at most 47.
For the estimation of the regulations in Table 2(a), the
proposed approach outperforms other approaches in
terms of true positives. The proposed approach contains
more false positives than ENet1, G1DBN1, and
Table 2 A summary of results for system noise with standard deviation 1 and observation noise with standard
deviation 0.1
(a)
Equally spaced Unequally spaced
# of time points 50 25 50 25
# TP # FP PRE # TP # FP PRE # TP # FP PRE # TP # FP PRE
Proposed 295.9 41.7 0.88 238.4 71.6 0.77 262.4 42.1 0.86 110.7 37.2 0.75
ENet1 246.3 119.7 0.67 109.2 67 0.62 84.7 140.6 0.38 20.3 70.4 0.22
ENet2 277.9 130.9 0.68 212.8 130 0.62 169.7 241.5 0.41 65.5 132.5 0.33
G1DBN1 223.7 48 0.82 99.9 46.2 0.68 65.1 83.1 0.44 19.3 72.7 0.21
G1DBN2 268.8 83.4 0.76 188.1 64.5 0.74 134.8 104.4 0.56 46.7 85.7 0.35
(b)
Equally spaced Unequally spaced
# of time points 50 25 50 25
# TP # FP PRE # TP # FP PRE # TP # FP PRE # TP # FP PRE
Proposed 39.8 13.2 0.75 23.4 20.8 0.53 31.2 16.5 0.65 5.5 15.9 0.26
ENet1 38.5 153.1 0.2 18.6 113 0.14 12.3 186.6 0.06 3.7 85 0.04
ENet2 - - - - - - - - - - - -
G1DBN1 35.6 88.9 0.29 16.8 91.9 0.15 10.3 121.9 0.08 2.4 87.8 0.03
G1DBN2 - - - - - - - - - - - -
(a) The number of true positives (# TP) and false positives (# FP) of estimated regulations in two network model by the proposed approach, ENet1, ENet2,
G1DBN1, and G1DBN2 for equally and unequally spaced time series data. PRE denotes the precision of the results. Regulations in two networks are 305 in total.
(b) The number of true positives (# TP) and false positives (# FP) of changes on regulations between two network models estimated by the proposed approach,
ENet1, ENet2, G1DBN1, and G1DBN2 for equally and unequally spaced time series data. Since no changes are estimated by ENet2 and G1DBN2, their results are
indicated by ‘-’. The regulations changed in two networks are in total 47.
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G1DBN2 on the data of 25 time points. We further con-
sider these cases in terms of the precision. The preci-
sions of the proposed approach, ENet1, G1DBN1, and
G1DBN2 are given by 0.77, 0.62, 0.68, and 0.74, respec-
tively. From this analysis, the proposed approach shows
better performance than ENet2, G1DBN1, and G1DBN2
on the whole. More true positives are estimated by
ENet2 than ENet1, and the precisions of ENet2 tend to
be better than those of ENet1. This type of relationship
is also observed between G1DBN1 and G1DBN2. Also,
the elastic net based VAR model approaches estimate
more true positives than the approaches from G1DBN.
However, in the precision, the approaches from G1DBN
are better than the elastic net based VAR model
approaches. From the results in Table 2(b), we see that
the proposed approach estimates more true changes on
regulations than ENet1 and G1DBN1 on both data of 25
and 50 time points. In addition, the results of the pro-
posed approach contain less false positives than those of
ENet1 and G1DBN1. No changes on regulations are
detected in ENet2 and G1DBN2 as topological differ-
ences are ignored in these approaches. Since the pro-
posed approach considers differences on network
structures as well as uses two time series data efficiently,
it can provide better results than other approaches on
both estimating regulations and identifying changes on
regulations.
One may think it is strange that false positives in
ENet1 and G1DBN1 in Table 2(b) is more than those in
Table 2(a), but this case can occur from the following
reason. If a regulation exists in both of the true network
models of G1 and G2, but is estimated only for G1, then
the case is not counted as a false positive in Table 2(a)
while it is counted as a false positive in Table 2(b).
Thus, the number of false positives in Table 2(b) can be
greater than those in Table 2(a).
In order to show the performance in unequally spaced
time series data, we generate unequally spaced time ser-
ies data of 25 and 50 observed time points. For time ser-
ies data of 25 observed time points, we first generate
equally spaced time series data of 40 time points and
divide it into three blocks: 15 time points, 10 time
points, and 15 time points. We then remove time points
in the following manner: no time point is removed in
the first block; one of every two time points are
removed in the second block; and two of every three
time points are removed in the third block. Figure 3
shows the time point schedule of time series data
obtained in this process. For time series data of 50
observed time points, we first generate equally space
time series data of 80 time points, divide it into three
blocks: 30 time points, 20 time points, and 30 time
points. Then, some time points are removed in a similar
manner. We apply the proposed approach, ENet1,
ENet2, G1DBN1, and G1DBN2 to the unequally spaced
time series data. Results for the dataset are also sum-
marized in Tables 2(a) and 2(b). From the comparison
of results on equally and spaced time series data, the
results of the proposed approach from unequally spaced
time series data are worse than those from equally
spaced one even with the same number of observed
time points. However, results of ENet1, ENet2,
G1DBN1, and G1DBN2 are worsened more than those
of the proposed approach. This is probably because
unequally spaced time points break their assumption,
and their estimation process is misled.
We also consider the time series data with the high
level noise: system noise with standard deviation 1 and
observation noise with standard deviation 1. The results
for the case are summarized in Tables 3(a) and 3(b).
The proposed approach shows the better performance
on the number of true positives and precisions than
other approaches except for the identification of the
changes on regulations from the equally spaced time
series data of 50 time points. For equally spaced time
series data of 50 time points, the number of true posi-
tives on the changes on regulations estimated by the
proposed approach is more than that of G1DBN1, but
less than that of ENet1. However, the precisions on the
estimated changes by both ENet1 and G1DBN are much
worse than the proposed approach. Thus, overall, the
proposed approach is more effective than other meth-
ods. Although the proposed approach provides the bet-
ter performance than other methods, the results of all
Figure 3 A time point schedule on unequally spaced time series data in the Monte Carlo experiment. Observed points in the time
schedule are indicated by arrows. 15 time points are equally spaced in first block, every second point is observed in second block comprised of
5 observed time points, and every third point is observed in third block comprised of 5 observed time points.
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the approaches are worsened due to the high level noise,
and the differences on the performance among the
approaches get smaller, compared to the case of obser-
vation noise with standard deviation 0.1.
Analysis of time series microarray data from Human small
airway epithelial cells
We apply the proposed approach to two time series
microarray gene expression data from normal Human
small airway epithelial cells (SAECs) and SAECs treated
by stimulating EGF-receptors and dosing an anticancer
drug termed Gefitinib. EGF-receptors are often overex-
pressed in lung cancer cells such as tumoral SAECs, and
a lung cancer condition is simulated in the treated
SAECs by stimulating EGF-receptors. Since Gefitinib is
known as a selective inhibiter of EGF-receptors, the sti-
mulation of EGF-receptors would be counteracted by
Gefitinib, and the condition of treated SACEs should be
the same as that of normal SAECs in theory. However,
since some gene expression patterns are different
between the two conditions in practice, some unknown
effects by Gefitinib may be involved in the phenomenon.
Thus, we focus on changed regulations between the
gene networks estimated from gene expression data in
these two conditions in order to find some insights on
the unknown effects of Gefitinib.
For gene set selection, we first screen 500 genes from
the ranking of the gene list sorted by coefficient
variation [5]. We then select 100 genes with highly var-
ied expression profiles between normal SAECs and trea-
ted SAECs. The time series gene expression data from
both types of cells are comprised of spaced 14 time
points in 48 hours. The time schedule of 14 time points
are {0 h, 6 h, 9 h, 12 h, 15 h, 18 h, 21 h, 24 h, 27 h, 30
h, 33 h, 36 h, 39 h, 48 h}. For the analysis on the pro-
posed approach, we set interval on system model to
three hours.
Table 3 A summary of results for system noise with standard deviation 1 and observation noise with standard
deviation 1
(a)
Equally spaced Unequally spaced
# of time points 50 25 50 25
# TP # FP PRE # TP # FP PRE # TP # FP PRE # TP # FP PRE
Proposed 190.2 122.8 0.61 88.1 121.0 0.42 132.1 675.5 0.66 52.1 108.9 0.33
ENet1 110.8 136.9 0.45 30.3 75.9 0.29 32.5 133.7 0.2 7.4 75.2 0.09
ENet2 189.8 218 0.47 85.8 136.2 0.39 75.9 180.7 0.3 23.5 123.3 0.16
GIDBN1 86.6 82.6 0.51 22.6 90.8 0.2 26.3 74 0.26 7.1 71.6 0.09
GIDBN2 163.9 105.7 0.61 54.4 99 0.35 66.2 91.2 0.42 17.4 92.8 0.16
(b)
Equally spaced Unequally spaced
# of time points 50 25 50 25
# TP # FP PRE # TP # FP PRE # TP # FP PRE # TP # FP PRE
Proposed 15.4 43.6 0.26 4.7 50.0 0.09 8.1 16.7 0.33 3.1 42.5 0.07
ENet1 16.9 184 0.08 3.8 95.4 0.04 5.2 155 0.03 1.2 81.4 0.01
ENet2 - - - - - - - - - - - -
GIDBN1 14.5 125.1 0.1 3.9 105.7 0.04 4 91.9 0.04 1.7 76.8 0.02
GIDBN2 - - - - - - - - - - - -
(a) The number of true positives (# TP) and false positives (# FP) of estimated regulations in two network model by the proposed approach, ENet1, ENet2,
G1DBN1, and G1DBN2 for equally and unequally spaced time series data. PRE denotes the precision of the results. Regulations in two networks are 305 in total.
(b) The number of true positives (# TP) and false positives (# FP) of changes on regulations between two network models estimated by the proposed approach,
ENet1, ENet2, G1DBN1, and G1DBN2 for equally and unequally spaced time series data. Since no changes are estimated by ENet2 and G1DBN2, their results are
indicated by ‘-’. The regulations changed in two networks are in total 47.
Table 4 Changes on regulations between normal and
treated SAECs
Normal SAECs Treated SAECs
ZC3HAV1L ® FOXA2 Prss22 ® foxn2
LIF ® foxn2 Prss22 ® cdk14
Cdc42ep2 ® Spink6 Prss22 ® Camk2n1
Siglec15 ® NTN1 Prss22 ® cttn
HAS3 ® HAS3 Prss22 ® Sfrs6
HAS3 ® Enc1 Prss22 ® ITGA2
HAS3 ® LEPREL1 Prss22 ® pkn2
Prss22 ® Hs2st1
Prss22 ® FILIP1L
Prss22 ® Hcn2
Prss22 ® KLF16
Ktelc1 ® NTN1
Tm6sf1 ® Siglec15
Estimated regulations only in normal or treated SAECs are listed in the left
side or right side, respectively.
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The estimated networks from time series gene expres-
sion data in normal SAECs and treated SAECs are sum-
marized and given in Figure 4. Black arrows, red arrows,
and green arrows indicate regulations in both condi-
tions, only in normal SAECs, and only in treated
SAECs, respectively. Table 4 gives a list of the estimated
regulations only in normal SAECs or in treated SAEC.
From Table 4, we see that Prss22 is involved in most
of the regulations only in treated SAECs. Prss22 is a
tryptase, one of serine proteases, and its relationship
with the airways is suggested by a report about its
expression in the airways in a developmentally regulated
manner. Tryptase is a potent mitogen of fibroblast [15],
and it is reported that the increase and activation of
fibroblast are promoted in lung cells under the condi-
tion of interstitial pneumonia. Interstitial pneumonia is
known as a side effect of Gefitinib, and these findings
suggest that Prss22 is an off-target of Gefitinib and is
Figure 4 An estimated gene network by the proposed approach from time series gene expression data on normal SAECs and treated
SAECs. In the estimated network, regulations in both conditions are in black, and regulations only in normal SAECs and treated SAECs are in
red and green, respectively.
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possibly related to the side effect of Gefitinib. Also,
FILIP1L, a gene estimated as one of targets of Prss22 in
treated SAECs, is reported as an inhibitor of cell prolif-
eration of fibroblast [16]. This observation supports the
relation between Prss22 and fibroblast as well.
We also focus on other several genes related to
changes on regulations in normal and treated SAECs.
LIF, leukemia inhibitory factor, is known to affect cell
growth and development. Gefitinib is also known to be
effective for acute myelogenous leukemia via Sky, which
is an off-target gene of Gefitinib [17]. In addition, Wang
et al. reported that LIF prolongs the cell cycle of stem
cells on acute myelogenous leukemia lines [18].
Although, to the best of our knowledge, no direct influ-
ence from Gefitinib to LIF is reported, the above facts
suggest some relation between Gefitinib and LIF, and
support changes on regulations of LIF between normal
and treated SAECs.
Heikema et al. reported that Human Siglecs, Siglecs-
14, -15, and -16 interact with transmembrain adaptor
proteins containing the immunoreceptor tyrosine-based
activation motif such as DAP12 [19], and therefore they
potentially mediate the activation of intracellular signal-
ing. Gefitinib is a selective inhibitor of tyrosine kinase,
and the inhibition of tyrosine kinase is considered to
affect the regulations around Siglec-15.
Although the stimulation of EGF-receptors in the trea-
ted SAECs is considered to be counteracted by Gefitinib,
the expressions of some genes may be affected by the
stimulation in practical conditions. HAS3 is related to
synthesis of the unbranched glycosaminoglycan hyaluro-
nic acid and is reported to be up-regulated by EGF [20].
The stimulation of EGF-receptors affects the amount of
EGF taken into cells, and hence the stimulation is
expected to cause the changes on the regulations around
HAS3. Foxn2 is a member of family of Fox proteins. Fox
proteins are known to play important roles on control-
ling the expressions of genes related to cell growth, pro-
liferation, and differentiation. Some members of Fox
family are related to EFG-receptors, e.g., the expression
of Foxn1 is suppressed by EGF-receptor signaling [21]
although no direct relation between EGF-receptors and
Foxn2 is found. FOXA2 is also a member of family of
Fox proteins. EGF-receptor signaling is known to
decrease the expression of FOXA, which prevents the
mucus production [22]. [23] reported the relation
between EGF-receptors and FOXA2 in the airways of
asthmatic patients. Thus, it appears that the change on
the regulation related to FOXA2 is caused by the stimu-
lation of EGF-receptors.
Conclusions
We proposed the new computational model that is
based on VAR-SSM and estimates gene networks from
time series data on normal and treated conditions as
well as identifies changes regulations by the treatment.
Unlike many of existing gene network estimation
approaches assuming equally spaced time points, our
approach can handle unequally spaced time series data.
The efficient use of time series data is achieved by
representing the presence of regulations on each condi-
tion with hidden binary variables. Since finding the opti-
mal configuration of the hidden binary variables on the
proposed model is computationally in tractable, we
derive the extended variational annealing method in
order to address the problem as the alternative method.
In the Monte Carlo experiments, we use equally and
spaced time series data from synthetically generated two
regulatory networks whose structures are different in
several regulations, and verified the effectiveness of the
proposed model in both estimation of regulations and
changes on regulations between the two conditions,
compared to existing methods.
As the real data application, we use the proposed
approach to analyze two time series data from normal
SAECs and SAECs treated by stimulating EGF-receptors
and dosing Gefitinib. From genes related to changes on
regulations by the treatment, we find possible off-target
genes of Gefitinib, and one of these genes is suggested
to be related to a factor of interstitial pneumonia, which
is known as a side effect of Gefitinib. In this study, we
consider changes on regulations in two conditions, but
the proposed approach can be extended to identifying
changes among more than two conditions.
Additional material
Additional file 1: Proof of Proposition 1 and more details on the
procedures of variational annealing. A proof of Proposition 1 and
more details on the procedures of variational annealing on the proposed
model are described.
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